REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $240,626 | +22.9% | 2,360 | +9.6% | 0.01% | +12.5% |
| Q1 2023 | $195,751 | +116.9% | 2,153 | 0.0% | 0.01% | +100.0% |
| Q4 2022 | $90,254 | +67.1% | 2,153 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $54,000 | -16.9% | 2,153 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $65,000 | -8.5% | 2,153 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $71,000 | +24.6% | 2,153 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $57,000 | -73.7% | 2,153 | 0.0% | 0.00% | -75.0% |
| Q3 2021 | $217,000 | -28.9% | 2,153 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $305,000 | +6.3% | 2,153 | +8.4% | 0.01% | -31.2% |
| Q1 2020 | $287,000 | -25.6% | 1,987 | +5.4% | 0.02% | -5.9% |
| Q4 2019 | $386,000 | +181.8% | 1,886 | +10.2% | 0.02% | +183.3% |
| Q3 2019 | $137,000 | -15.4% | 1,712 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $162,000 | +24.6% | 1,712 | +12.4% | 0.01% | +16.7% |
| Q1 2019 | $130,000 | +52.9% | 1,523 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $85,000 | -32.0% | 1,523 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $125,000 | +171.7% | 1,523 | +16.3% | 0.01% | +200.0% |
| Q2 2018 | $46,000 | +206.7% | 1,310 | +75.4% | 0.00% | +100.0% |
| Q1 2018 | $15,000 | -28.6% | 747 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,000 | -4.5% | 747 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $22,000 | -8.3% | 747 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $24,000 | +140.0% | 747 | +68.6% | 0.00% | – |
| Q1 2017 | $10,000 | – | 443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |